Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
What the Research Says About Safety Clinical studies on AOD9604 indicate that the peptide is generally welltolerated: In human trials, no significant adverse effects were reported at doses up to 1 mg/day (safety summary) Unlike growth hormone therapies, AOD9604 does not meaningfully elevate IGF1 levels (human data), which may reduce the risk of unwanted growthrelated side effects
When AOD 9604 binds to fat cells, it upregulates lipolysis, the process of breaking stored triglycerides into free fatty acids and glycerol that the body can then use for energy
Taking both can boost blood cell production and energy
The MHRA has issued clear guidance on the risks associated with unlicensed medicines and research chemicals being marketed for weight loss or body composition purposes
The FDA does not approve compounded medications for safety, quality, or manufacturing
